And
regulate drug prices directly, as does every other country.
That reality would seem to suggest that the U.S. should adopt a system similar to those in other countries, which more tightly
regulate drug prices and where the government largely subsidizes health care costs (as opposed to employers largely doing so in the U.S.) through what's known as a single - payer system.
With Peter Bach of Memorial Sloan Kettering; Steve Miller of Express Scripts; Vijay Pande of Andreessen Horowitz; and Alan Murray of Fortune — Report by Jen Wieczner — Video: The Pros and Cons of
Regulating Drug Prices — Video of the entire session
Not exact matches
If we choose to
regulate the industry, we have to be willing to pay the
price for that, which means there won't be cheap antimalarial
drugs developed and there won't be potential biofuels developed and other
drugs for other diseases and cleaning up the environment and all the things that come from this area.
The former is
regulated by the U.S. Food and
Drug Administration (FDA) and requires strict certification, which often explains the related
price hike.
Pharmacies would buy
drugs from manufacturers at the Formulary
price, and dispense them to customers at the Formulary
price, plus
regulated mark - ups and dispensing fees.
[3] The sale and
pricing of generic
drugs is provincially
regulated.